Publicaciones en las que colabora con María Sanjurjo Sáez (45)

2023

  1. Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

    European Journal of Hospital Pharmacy

2022

  1. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

    Frontiers in Public Health, Vol. 10

  2. Implementation and evaluation of a home pharmaceutical care model through Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 36-46

  3. Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

    JMIR mHealth and uHealth, Vol. 10, Núm. 2

  4. Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 173-181

  5. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease

    Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 4, pp. 548-551

2021

  1. Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

    Frontiers in Oncology, Vol. 11

  2. Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

    Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 3, pp. 751-755

2020

  1. Assessing apps for patients with genitourinary tumors using the mobile application rating scale (MARS): Systematic search in app stores and content analysis

    JMIR mHealth and uHealth, Vol. 8, Núm. 7

  2. Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app

    Journal of Oncology Pharmacy Practice, Vol. 26, Núm. 1, pp. 105-115

  3. Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients with Cancer on Their Health Outcomes: Quasi-Experimental Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 10

  4. Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 299-301

  5. Features and functionalities of smartphone apps related to COVID-19: Systematic search in app stores and content analysis

    Journal of Medical Internet Research, Vol. 22, Núm. 8

  6. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents

    American Journal of Health-System Pharmacy, Vol. 77, Núm. 17, pp. 1393-1402

  7. Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

    Expert Opinion on Drug Safety, Vol. 19, Núm. 8, pp. 1041-1048

  8. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2019

  1. Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

    Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520

  2. Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice

    Expert Opinion on Drug Safety, Vol. 18, Núm. 9, pp. 861-868

  3. Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

    Journal of Evaluation in Clinical Practice, Vol. 25, Núm. 1, pp. 28-35

2018

  1. Association between clinical factors and dose modification strategies in the treatment with ustekinumab for moderate-to-severe plaque psoriasis

    Journal of Dermatological Treatment, Vol. 29, Núm. 8, pp. 792-796